Iván Martínez‐Forero

2.0k total citations · 1 hit paper
29 papers, 1.4k citations indexed

About

Iván Martínez‐Forero is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Iván Martínez‐Forero has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 12 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Iván Martínez‐Forero's work include Immunotherapy and Immune Responses (17 papers), T-cell and B-cell Immunology (15 papers) and Immune Cell Function and Interaction (12 papers). Iván Martínez‐Forero is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), T-cell and B-cell Immunology (15 papers) and Immune Cell Function and Interaction (12 papers). Iván Martínez‐Forero collaborates with scholars based in Spain, United States and France. Iván Martínez‐Forero's co-authors include Ignacio Melero, José Luis Perez‐Gracia, Asís Palazón, Miguel F. Sanmamed, Ana Rouzaut, Aizea Morales‐Kastresana, Sandra Hervás‐Stubbs, Álvaro Teijeira, Mariano Ponz‐Sarvisé and Pablo Villoslada and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Iván Martínez‐Forero

29 papers receiving 1.4k citations

Hit Papers

Paradigms on Immunotherapy Combinations with Chemotherapy 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iván Martínez‐Forero Spain 20 909 825 297 112 105 29 1.4k
Thomas U. Marron United States 17 766 0.8× 520 0.6× 337 1.1× 82 0.7× 96 0.9× 87 1.4k
Rong En Tay United States 5 894 1.0× 890 1.1× 571 1.9× 173 1.5× 97 0.9× 8 1.5k
Michael A. Cannarile Switzerland 16 1.3k 1.4× 770 0.9× 435 1.5× 157 1.4× 57 0.5× 27 1.9k
Nicole M. McLaughlin Australia 12 925 1.0× 779 0.9× 318 1.1× 81 0.7× 39 0.4× 12 1.5k
Stéphanie Corgnac France 16 938 1.0× 748 0.9× 339 1.1× 104 0.9× 41 0.4× 28 1.3k
Andrew J. Rech United States 14 931 1.0× 1.1k 1.3× 418 1.4× 155 1.4× 50 0.5× 24 1.6k
Miren Zuazo Spain 17 760 0.8× 1.0k 1.2× 296 1.0× 123 1.1× 65 0.6× 27 1.4k
María Gato Spain 16 766 0.8× 848 1.0× 306 1.0× 116 1.0× 49 0.5× 23 1.3k
Muhammad Baghdadi Japan 20 1.3k 1.4× 827 1.0× 422 1.4× 112 1.0× 87 0.8× 32 1.7k
Dennis O. Adeegbe United States 18 1.2k 1.3× 845 1.0× 487 1.6× 164 1.5× 72 0.7× 31 1.9k

Countries citing papers authored by Iván Martínez‐Forero

Since Specialization
Citations

This map shows the geographic impact of Iván Martínez‐Forero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iván Martínez‐Forero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iván Martínez‐Forero more than expected).

Fields of papers citing papers by Iván Martínez‐Forero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iván Martínez‐Forero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iván Martínez‐Forero. The network helps show where Iván Martínez‐Forero may publish in the future.

Co-authorship network of co-authors of Iván Martínez‐Forero

This figure shows the co-authorship network connecting the top 25 collaborators of Iván Martínez‐Forero. A scholar is included among the top collaborators of Iván Martínez‐Forero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iván Martínez‐Forero. Iván Martínez‐Forero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Merle, Philippe, Masatoshi Kudo, Julien Edeline, et al.. (2023). Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial. Liver Cancer. 12(4). 309–320. 31 indexed citations
2.
Salas‐Benito, Diego, José Luis Perez‐Gracia, Mariano Ponz‐Sarvisé, et al.. (2021). Paradigms on Immunotherapy Combinations with Chemotherapy. Cancer Discovery. 11(6). 1353–1367. 278 indexed citations breakdown →
3.
Zapata, Juan M., Gema Pérez-Chacón, Iván Martínez‐Forero, et al.. (2018). CD137 (4-1BB) Signalosome: Complexity Is a Matter of TRAFs. Frontiers in Immunology. 9. 2618–2618. 78 indexed citations
4.
Weigelin, Bettina, Elixabet Bolaños, Álvaro Teijeira, et al.. (2015). Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb. Proceedings of the National Academy of Sciences. 112(24). 7551–7556. 81 indexed citations
5.
Morales‐Kastresana, Aizea, Miguel F. Sanmamed, Inmaculada Rodríguez, et al.. (2013). Combined Immunostimulatory Monoclonal Antibodies Extend Survival in an Aggressive Transgenic Hepatocellular Carcinoma Mouse Model. Clinical Cancer Research. 19(22). 6151–6162. 81 indexed citations
6.
Moreno, Beatriz, et al.. (2013). Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity. BMC Systems Biology. 7(1). 34–34. 21 indexed citations
7.
Martínez‐Forero, Iván, Arantza Azpilikueta, Elixabet Bolaños, et al.. (2013). T Cell Costimulation with Anti-CD137 Monoclonal Antibodies Is Mediated by K63–Polyubiquitin-Dependent Signals from Endosomes. The Journal of Immunology. 190(12). 6694–6706. 52 indexed citations
8.
Palazón, Asís, Álvaro Teijeira, Iván Martínez‐Forero, et al.. (2011). Agonist Anti-CD137 mAb Act on Tumor Endothelial Cells to Enhance Recruitment of Activated T Lymphocytes. Cancer Research. 71(3). 801–811. 112 indexed citations
9.
Alfaro, Carlos, Natalia Suárez, Iván Martínez‐Forero, et al.. (2011). Carcinoma-Derived Interleukin-8 Disorients Dendritic Cell Migration Without Impairing T-Cell Stimulation. PLoS ONE. 6(3). e17922–e17922. 34 indexed citations
10.
Alfaro, Carlos, Natalia Suárez, Carmen Oñate, et al.. (2011). Dendritic Cells Take up and Present Antigens from Viable and Apoptotic Polymorphonuclear Leukocytes. PLoS ONE. 6(12). e29300–e29300. 29 indexed citations
11.
Mendizábal, Nieves Vélez de, Jorge Carneiro, Ricard V. Solé, et al.. (2011). Modeling the effector - regulatory T cell cross-regulation reveals the intrinsic character of relapses in Multiple Sclerosis. BMC Systems Biology. 5(1). 114–114. 34 indexed citations
12.
Dubrot, Juan, Asís Palazón, Carlos Alfaro, et al.. (2010). Intratumoral injection of interferon‐α and systemic delivery of agonist anti‐CD137 monoclonal antibodies synergize for immunotherapy. International Journal of Cancer. 128(1). 105–118. 37 indexed citations
13.
Mendizábal, Nieves Vélez de, Iván Martínez‐Forero, Marı́a J. Garrido, et al.. (2010). A Semi-physiological-Based Pharmacokinetic/Pharmacodynamic Model to Describe the Effects of Topotecan on B-Lymphocyte Lineage Cells. Pharmaceutical Research. 27(3). 431–441. 3 indexed citations
14.
Dubrot, Juan, Carlos Alfaro, Asís Palazón, et al.. (2010). Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ. Cancer Immunology Immunotherapy. 59(8). 1223–1233. 82 indexed citations
15.
Martínez‐Forero, Iván, et al.. (2010). Steady State Detection of Chemical Reaction Networks Using a Simplified Analytical Method. PLoS ONE. 5(6). e10823–e10823. 14 indexed citations
16.
Rouzaut, Ana, Saray Garasa, Álvaro Teijeira, et al.. (2010). Dendritic cells adhere to and transmigrate across lymphatic endothelium in response to IFN‐α. European Journal of Immunology. 40(11). 3054–3063. 48 indexed citations
17.
Suárez, Natalia, Carlos Alfaro, Juan Dubrot, et al.. (2010). Synergistic effects of CTLA‐4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivo. International Journal of Cancer. 129(2). 374–386. 13 indexed citations
18.
Martínez‐Forero, Iván, et al.. (2008). Pharmacogenomics of multiple sclerosis: in search for a personalized therapy. Expert Opinion on Pharmacotherapy. 9(17). 3053–3067. 19 indexed citations
19.
Martínez‐Forero, Iván, et al.. (2008). Tr1 cells in the neat sighting-pole. 27(2). 78–84. 1 indexed citations
20.
Palácios, Ricardo, Joaquín Goñi, Iván Martínez‐Forero, et al.. (2007). A Network Analysis of the Human T-Cell Activation Gene Network Identifies Jagged1 as a Therapeutic Target for Autoimmune Diseases. PLoS ONE. 2(11). e1222–e1222. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026